Labetuzumab govitecan (IMMU 130) is an Anti-CEACAM5/SN-38 antibody-drug conjugate (ADC). Labetuzumab govitecan consists of the antibody Labetuzumab, SN-38, and a pH-sensitive Linker. Labetuzumab govitecan can be used for research of cancers, such as colorectal cancer[1][2][3].
Molecular Weight:
154000 (average)
Purity:
98.66
CAS Number:
[1469876-18-3]
Target:
Antibody-Drug Conjugates (ADCs)
Application Notes:
ADC Related
* VAT and and shipping costs not included. Errors and price changes excepted